On July 2, 2025, Applied DNA Sciences, Inc. received notice from Nasdaq confirming it regained compliance with listing rules, ensuring its shares remain traded on the exchange. The previously scheduled Nasdaq hearing for July 15, 2025 has been canceled as a result.